These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 17318886

  • 1. Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO.
    Seeman P, McCormick PN, Kapur S.
    Synapse; 2007 May; 61(5):263-7. PubMed ID: 17318886
    [Abstract] [Full Text] [Related]

  • 2. Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.
    Seeman P, Tallerico T, Ko F, Tenn C, Kapur S.
    Synapse; 2002 Dec 15; 46(4):235-9. PubMed ID: 12373738
    [Abstract] [Full Text] [Related]

  • 3. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L, Wilson AA, Garcia A, Houle S, Kapur S, Ginovart N.
    Synapse; 2006 Aug 15; 60(2):172-83. PubMed ID: 16715499
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
    Seeman P.
    Synapse; 2009 Mar 15; 63(3):186-92. PubMed ID: 19086090
    [Abstract] [Full Text] [Related]

  • 5. Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.
    Seeman P.
    Synapse; 2012 Jan 15; 66(1):88-93. PubMed ID: 21954082
    [Abstract] [Full Text] [Related]

  • 6. Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNO.
    Seeman P, Battaglia G, Corti C, Corsi M, Bruno V.
    Synapse; 2009 Mar 15; 63(3):247-51. PubMed ID: 19084908
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
    McCormick PN, Kapur S, Seeman P, Wilson AA.
    Nucl Med Biol; 2008 Jan 15; 35(1):11-7. PubMed ID: 18158938
    [Abstract] [Full Text] [Related]

  • 8. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T, Seeman P, Kuroiwa M, Nishi A.
    Eur J Neurosci; 2008 May 15; 27(10):2551-7. PubMed ID: 18489579
    [Abstract] [Full Text] [Related]

  • 9. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
    McCormick PN, Kapur S, Reckless G, Wilson AA.
    Synapse; 2009 Nov 15; 63(11):998-1009. PubMed ID: 19598174
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
    Kiss B, Horti F, Bobok A.
    Synapse; 2011 Jun 15; 65(6):467-78. PubMed ID: 20936685
    [Abstract] [Full Text] [Related]

  • 11. Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.
    Seeman P.
    Synapse; 2007 Dec 15; 61(12):1013-8. PubMed ID: 17853435
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptors labelled by PHNO.
    Seeman P, Ulpian C, Larsen RD, Anderson PS.
    Synapse; 1993 Aug 15; 14(4):254-62. PubMed ID: 7902615
    [Abstract] [Full Text] [Related]

  • 13. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.
    J Neurochem; 2006 May 15; 97(4):1089-103. PubMed ID: 16606355
    [Abstract] [Full Text] [Related]

  • 14. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P, Ko F, Willeit M, McCormick P, Ginovart N.
    Synapse; 2005 Nov 15; 58(2):122-8. PubMed ID: 16088951
    [Abstract] [Full Text] [Related]

  • 15. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
    Seeman P, Tallerico T, Ko F.
    Synapse; 2003 Sep 15; 49(4):209-15. PubMed ID: 12827639
    [Abstract] [Full Text] [Related]

  • 16. Elevated dopamine D2High receptors in alpha-1b-adrenoceptor knockout supersensitive mice.
    Tassin JP, Torrens Y, Salomon L, Lanteri C, Seeman P.
    Synapse; 2007 Jul 15; 61(7):569-72. PubMed ID: 17447259
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D2(High) receptors on intact cells.
    Seeman P.
    Synapse; 2008 Apr 15; 62(4):314-8. PubMed ID: 18241049
    [Abstract] [Full Text] [Related]

  • 18. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A, Eller M, Herm L, Rinken A, Harro J.
    Brain Res; 2007 Feb 02; 1131(1):138-48. PubMed ID: 17156751
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO.
    Nobrega JN, Seeman P.
    Synapse; 1994 Jul 02; 17(3):167-72. PubMed ID: 7974199
    [Abstract] [Full Text] [Related]

  • 20. Alcohol-withdrawn animals have a prolonged increase in dopamine D2high receptors, reversed by general anesthesia: relation to relapse?
    Seeman P, Tallerico T, Ko F.
    Synapse; 2004 May 02; 52(2):77-83. PubMed ID: 15034913
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.